| ENSG00000223979.2 |
GSK269962A |
Breast invasive carcinoma |
0.04505563 |
Resistant |
| ENSG00000227070.1 |
GSK269962A |
Breast invasive carcinoma |
0.041381803 |
Resistant |
| ENSG00000229512.1 |
GSK269962A |
Breast invasive carcinoma |
0.030538476 |
Resistant |
| ENSG00000231830.1 |
GSK269962A |
Breast invasive carcinoma |
0.044348273 |
Resistant |
| ENSG00000237036.4 |
GSK269962A |
Breast invasive carcinoma |
0.037230275 |
Resistant |
| ENSG00000253404.1 |
GSK269962A |
Breast invasive carcinoma |
0.038119007 |
Resistant |
| ENSG00000261220.2 |
GSK269962A |
Breast invasive carcinoma |
0.032519399 |
Resistant |
| ENSG00000273464.1 |
GSK269962A |
Breast invasive carcinoma |
0.001484199 |
Resistant |
| ENSG00000273487.1 |
GSK269962A |
Breast invasive carcinoma |
0.00883141 |
Resistant |
| ENSG00000182376.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048694085 |
Resistant |
| ENSG00000212163.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002510211 |
Resistant |
| ENSG00000213971.3 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027059541 |
Resistant |
| ENSG00000223935.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038279062 |
Resistant |
| ENSG00000226856.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047694314 |
Resistant |
| ENSG00000226957.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042144479 |
Resistant |
| ENSG00000228113.3 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030529565 |
Resistant |
| ENSG00000228397.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016333982 |
Resistant |
| ENSG00000228624.3 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047317799 |
Resistant |
| ENSG00000229043.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034228645 |
Resistant |
| ENSG00000229697.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004519642 |
Resistant |
| ENSG00000229862.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048426018 |
Resistant |
| ENSG00000230310.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044792853 |
Resistant |
| ENSG00000230423.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005693313 |
Resistant |
| ENSG00000230896.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01833909 |
Resistant |
| ENSG00000231429.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00570923 |
Resistant |
| ENSG00000231481.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007379712 |
Resistant |
| ENSG00000231764.4 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049647897 |
Resistant |
| ENSG00000232719.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044367437 |
Resistant |
| ENSG00000232977.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029983851 |
Resistant |
| ENSG00000234232.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021694007 |
Resistant |
| ENSG00000234393.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047269493 |
Resistant |
| ENSG00000234689.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005586245 |
Resistant |
| ENSG00000234707.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001729511 |
Resistant |
| ENSG00000235079.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020139488 |
Resistant |
| ENSG00000235488.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03648288 |
Resistant |
| ENSG00000235527.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032829274 |
Resistant |
| ENSG00000235560.3 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029598915 |
Resistant |
| ENSG00000235795.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044555853 |
Resistant |
| ENSG00000235802.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022032187 |
Resistant |
| ENSG00000236137.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043041157 |
Resistant |
| ENSG00000236364.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036495229 |
Resistant |
| ENSG00000236651.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036193437 |
Resistant |
| ENSG00000244791.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02490409 |
Resistant |
| ENSG00000245148.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039796629 |
Resistant |
| ENSG00000245573.3 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043152311 |
Resistant |
| ENSG00000246090.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023578066 |
Resistant |
| ENSG00000248152.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049907017 |
Resistant |
| ENSG00000251168.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046407351 |
Resistant |
| ENSG00000251556.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048680188 |
Resistant |
| ENSG00000251603.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026756215 |
Resistant |
| ENSG00000253315.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033375452 |
Resistant |
| ENSG00000253616.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039149059 |
Resistant |
| ENSG00000253636.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018791771 |
Resistant |
| ENSG00000253736.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022542414 |
Resistant |
| ENSG00000253848.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029704609 |
Resistant |
| ENSG00000254900.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042997154 |
Resistant |
| ENSG00000255670.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030827476 |
Resistant |
| ENSG00000256234.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032506046 |
Resistant |
| ENSG00000257354.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00209504 |
Resistant |
| ENSG00000257534.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028242502 |
Resistant |
| ENSG00000258122.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035221758 |
Resistant |
| ENSG00000258673.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034859101 |
Resistant |
| ENSG00000259417.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004980028 |
Resistant |
| ENSG00000260063.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002255525 |
Resistant |
| ENSG00000260132.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046256929 |
Resistant |
| ENSG00000260288.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040155928 |
Resistant |
| ENSG00000260470.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034910229 |
Resistant |
| ENSG00000260510.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034131462 |
Resistant |
| ENSG00000261293.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023931431 |
Resistant |
| ENSG00000261474.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013760097 |
Resistant |
| ENSG00000261670.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033216048 |
Resistant |
| ENSG00000262686.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042806365 |
Resistant |
| ENSG00000264125.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011763201 |
Resistant |
| ENSG00000265908.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015612435 |
Resistant |
| ENSG00000265943.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030804371 |
Resistant |
| ENSG00000266040.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049254459 |
Resistant |
| ENSG00000267613.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031019728 |
Resistant |
| ENSG00000267924.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045049888 |
Resistant |
| ENSG00000268364.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010656635 |
Resistant |
| ENSG00000269107.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030201048 |
Resistant |
| ENSG00000270066.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03439518 |
Resistant |
| ENSG00000270117.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019393888 |
Resistant |
| ENSG00000270159.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02819914 |
Resistant |
| ENSG00000270177.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040131136 |
Resistant |
| ENSG00000270462.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012325367 |
Resistant |
| ENSG00000271927.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027899921 |
Resistant |
| ENSG00000272425.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008702977 |
Resistant |
| ENSG00000272754.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043640145 |
Resistant |
| ENSG00000272777.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026933093 |
Resistant |
| ENSG00000273232.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038626236 |
Resistant |
| ENSG00000273406.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012908478 |
Resistant |
| ENSG00000174365.15 |
GSK269962A |
Esophageal cancer |
0.018599416 |
Resistant |
| ENSG00000177410.8 |
GSK269962A |
Esophageal cancer |
0.01410239 |
Resistant |
| ENSG00000179406.6 |
GSK269962A |
Esophageal cancer |
0.01395639 |
Resistant |
| ENSG00000179523.4 |
GSK269962A |
Esophageal cancer |
0.017627244 |
Resistant |
| ENSG00000180769.4 |
GSK269962A |
Esophageal cancer |
0.026521362 |
Resistant |
| ENSG00000185495.6 |
GSK269962A |
Esophageal cancer |
0.020606166 |
Resistant |
| ENSG00000196756.7 |
GSK269962A |
Esophageal cancer |
0.046733772 |
Resistant |
| ENSG00000198221.7 |
GSK269962A |
Esophageal cancer |
0.027606318 |
Resistant |
| ENSG00000203721.1 |
GSK269962A |
Esophageal cancer |
0.038457919 |
Resistant |
| ENSG00000204623.4 |
GSK269962A |
Esophageal cancer |
0.015552035 |
Resistant |
| ENSG00000206140.5 |
GSK269962A |
Esophageal cancer |
0.031264744 |
Resistant |
| ENSG00000214184.3 |
GSK269962A |
Esophageal cancer |
0.029297724 |
Resistant |
| ENSG00000214401.4 |
GSK269962A |
Esophageal cancer |
0.034674655 |
Resistant |
| ENSG00000223522.1 |
GSK269962A |
Esophageal cancer |
0.033237877 |
Resistant |
| ENSG00000223813.2 |
GSK269962A |
Esophageal cancer |
0.020308065 |
Resistant |
| ENSG00000223842.1 |
GSK269962A |
Esophageal cancer |
0.034383015 |
Resistant |
| ENSG00000224138.1 |
GSK269962A |
Esophageal cancer |
0.048338603 |
Resistant |
| ENSG00000224885.1 |
GSK269962A |
Esophageal cancer |
0.044800726 |
Resistant |
| ENSG00000224950.1 |
GSK269962A |
Esophageal cancer |
0.016092772 |
Resistant |
| ENSG00000225113.1 |
GSK269962A |
Esophageal cancer |
0.030106877 |
Resistant |
| ENSG00000225218.1 |
GSK269962A |
Esophageal cancer |
0.003255768 |
Resistant |
| ENSG00000225234.1 |
GSK269962A |
Esophageal cancer |
0.018604184 |
Resistant |
| ENSG00000225361.3 |
GSK269962A |
Esophageal cancer |
0.014080259 |
Resistant |
| ENSG00000225791.2 |
GSK269962A |
Esophageal cancer |
0.002212222 |
Resistant |
| ENSG00000226266.2 |
GSK269962A |
Esophageal cancer |
0.036646221 |
Resistant |
| ENSG00000226381.3 |
GSK269962A |
Esophageal cancer |
0.032221516 |
Resistant |
| ENSG00000226853.2 |
GSK269962A |
Esophageal cancer |
0.044377137 |
Resistant |
| ENSG00000226920.1 |
GSK269962A |
Esophageal cancer |
0.047962437 |
Resistant |
| ENSG00000226950.2 |
GSK269962A |
Esophageal cancer |
0.049043684 |
Resistant |
| ENSG00000227036.2 |
GSK269962A |
Esophageal cancer |
0.044225622 |
Resistant |
| ENSG00000227359.1 |
GSK269962A |
Esophageal cancer |
0.047582158 |
Resistant |
| ENSG00000227477.1 |
GSK269962A |
Esophageal cancer |
0.036593858 |
Resistant |
| ENSG00000227674.1 |
GSK269962A |
Esophageal cancer |
0.030779392 |
Resistant |
| ENSG00000227733.4 |
GSK269962A |
Esophageal cancer |
0.015673794 |
Resistant |
| ENSG00000228107.1 |
GSK269962A |
Esophageal cancer |
0.033004689 |
Resistant |
| ENSG00000228274.3 |
GSK269962A |
Esophageal cancer |
0.019994193 |
Resistant |
| ENSG00000228604.3 |
GSK269962A |
Esophageal cancer |
0.004170469 |
Resistant |
| ENSG00000229036.3 |
GSK269962A |
Esophageal cancer |
0.038853603 |
Resistant |
| ENSG00000229152.1 |
GSK269962A |
Esophageal cancer |
0.049012498 |
Resistant |
| ENSG00000229692.3 |
GSK269962A |
Esophageal cancer |
0.0245065 |
Resistant |
| ENSG00000229873.1 |
GSK269962A |
Esophageal cancer |
0.025674411 |
Resistant |
| ENSG00000229931.1 |
GSK269962A |
Esophageal cancer |
0.003204423 |
Resistant |
| ENSG00000229956.5 |
GSK269962A |
Esophageal cancer |
0.002767977 |
Resistant |
| ENSG00000230002.2 |
GSK269962A |
Esophageal cancer |
0.020402932 |
Resistant |
| ENSG00000230148.4 |
GSK269962A |
Esophageal cancer |
0.012661081 |
Resistant |
| ENSG00000230724.5 |
GSK269962A |
Esophageal cancer |
0.020043642 |
Resistant |
| ENSG00000230896.1 |
GSK269962A |
Esophageal cancer |
0.017206822 |
Resistant |
| ENSG00000231889.3 |
GSK269962A |
Esophageal cancer |
0.011896461 |
Resistant |
| ENSG00000232684.1 |
GSK269962A |
Esophageal cancer |
0.008455442 |
Resistant |
| ENSG00000232692.1 |
GSK269962A |
Esophageal cancer |
0.013299523 |
Resistant |
| ENSG00000233006.2 |
GSK269962A |
Esophageal cancer |
0.041684598 |
Resistant |
| ENSG00000233483.2 |
GSK269962A |
Esophageal cancer |
0.039564464 |
Resistant |
| ENSG00000234129.3 |
GSK269962A |
Esophageal cancer |
0.010549053 |
Resistant |
| ENSG00000234184.1 |
GSK269962A |
Esophageal cancer |
0.031491663 |
Resistant |
| ENSG00000234281.1 |
GSK269962A |
Esophageal cancer |
0.0387462 |
Resistant |
| ENSG00000235398.4 |
GSK269962A |
Esophageal cancer |
0.017533968 |
Resistant |
| ENSG00000235530.2 |
GSK269962A |
Esophageal cancer |
0.042582534 |
Resistant |
| ENSG00000235545.1 |
GSK269962A |
Esophageal cancer |
0.001801499 |
Resistant |
| ENSG00000236064.1 |
GSK269962A |
Esophageal cancer |
0.031784844 |
Resistant |
| ENSG00000236308.1 |
GSK269962A |
Esophageal cancer |
0.03685813 |
Resistant |
| ENSG00000236383.3 |
GSK269962A |
Esophageal cancer |
0.02796144 |
Resistant |
| ENSG00000236498.1 |
GSK269962A |
Esophageal cancer |
0.021592337 |
Resistant |
| ENSG00000236618.2 |
GSK269962A |
Esophageal cancer |
0.045716624 |
Resistant |
| ENSG00000236924.1 |
GSK269962A |
Esophageal cancer |
0.046773926 |
Resistant |
| ENSG00000237126.4 |
GSK269962A |
Esophageal cancer |
0.040448222 |
Resistant |
| ENSG00000237149.4 |
GSK269962A |
Esophageal cancer |
0.033049314 |
Resistant |
| ENSG00000237356.1 |
GSK269962A |
Esophageal cancer |
0.009515007 |
Resistant |
| ENSG00000239653.1 |
GSK269962A |
Esophageal cancer |
0.021682121 |
Resistant |
| ENSG00000240219.1 |
GSK269962A |
Esophageal cancer |
0.049881664 |
Resistant |
| ENSG00000240567.1 |
GSK269962A |
Esophageal cancer |
0.049191721 |
Resistant |
| ENSG00000241211.1 |
GSK269962A |
Esophageal cancer |
0.040537092 |
Resistant |
| ENSG00000241313.2 |
GSK269962A |
Esophageal cancer |
0.007220802 |
Resistant |
| ENSG00000242282.2 |
GSK269962A |
Esophageal cancer |
0.047790349 |
Resistant |
| ENSG00000243008.2 |
GSK269962A |
Esophageal cancer |
0.029412076 |
Resistant |
| ENSG00000243485.2 |
GSK269962A |
Esophageal cancer |
0.039296177 |
Resistant |
| ENSG00000243960.1 |
GSK269962A |
Esophageal cancer |
0.027441712 |
Resistant |
| ENSG00000244041.3 |
GSK269962A |
Esophageal cancer |
0.042302503 |
Resistant |
| ENSG00000244124.1 |
GSK269962A |
Esophageal cancer |
0.039103061 |
Resistant |
| ENSG00000245213.2 |
GSK269962A |
Esophageal cancer |
0.015702804 |
Resistant |
| ENSG00000245534.2 |
GSK269962A |
Esophageal cancer |
0.01314199 |
Resistant |
| ENSG00000245571.2 |
GSK269962A |
Esophageal cancer |
0.025597819 |
Resistant |
| ENSG00000246089.3 |
GSK269962A |
Esophageal cancer |
0.009590823 |
Resistant |
| ENSG00000246130.1 |
GSK269962A |
Esophageal cancer |
0.010961431 |
Resistant |
| ENSG00000246582.2 |
GSK269962A |
Esophageal cancer |
0.02712655 |
Resistant |
| ENSG00000247735.2 |
GSK269962A |
Esophageal cancer |
0.045615519 |
Resistant |
| ENSG00000248734.2 |
GSK269962A |
Esophageal cancer |
0.043482189 |
Resistant |
| ENSG00000249042.1 |
GSK269962A |
Esophageal cancer |
0.047614774 |
Resistant |
| ENSG00000250133.2 |
GSK269962A |
Esophageal cancer |
0.049131461 |
Resistant |
| ENSG00000251136.4 |
GSK269962A |
Esophageal cancer |
0.025527408 |
Resistant |
| ENSG00000251381.2 |
GSK269962A |
Esophageal cancer |
0.049707869 |
Resistant |
| ENSG00000253972.1 |
GSK269962A |
Esophageal cancer |
0.040393601 |
Resistant |
| ENSG00000254267.1 |
GSK269962A |
Esophageal cancer |
0.038368713 |
Resistant |
| ENSG00000254477.1 |
GSK269962A |
Esophageal cancer |
0.041120854 |
Resistant |
| ENSG00000254682.1 |
GSK269962A |
Esophageal cancer |
0.017132678 |
Resistant |
| ENSG00000254911.2 |
GSK269962A |
Esophageal cancer |
0.032563607 |
Resistant |
| ENSG00000255717.2 |
GSK269962A |
Esophageal cancer |
0.042014707 |
Resistant |
| ENSG00000256443.1 |
GSK269962A |
Esophageal cancer |
0.045112467 |
Resistant |
| ENSG00000257086.1 |
GSK269962A |
Esophageal cancer |
0.018773191 |
Resistant |
| ENSG00000257410.1 |
GSK269962A |
Esophageal cancer |
0.04660675 |
Resistant |
| ENSG00000257742.1 |
GSK269962A |
Esophageal cancer |
0.034376659 |
Resistant |
| ENSG00000258457.1 |
GSK269962A |
Esophageal cancer |
0.036192635 |
Resistant |
| ENSG00000258884.1 |
GSK269962A |
Esophageal cancer |
0.029819272 |
Resistant |
| ENSG00000259001.2 |
GSK269962A |
Esophageal cancer |
0.033156414 |
Resistant |
| ENSG00000259118.1 |
GSK269962A |
Esophageal cancer |
0.030252362 |
Resistant |
| ENSG00000259250.1 |
GSK269962A |
Esophageal cancer |
0.039537834 |
Resistant |
| ENSG00000259345.1 |
GSK269962A |
Esophageal cancer |
0.027585641 |
Resistant |
| ENSG00000259366.1 |
GSK269962A |
Esophageal cancer |
0.048107553 |
Resistant |
| ENSG00000259687.1 |
GSK269962A |
Esophageal cancer |
0.045324223 |
Resistant |
| ENSG00000259768.3 |
GSK269962A |
Esophageal cancer |
0.031199923 |
Resistant |
| ENSG00000259865.1 |
GSK269962A |
Esophageal cancer |
0.012464247 |
Resistant |
| ENSG00000259933.2 |
GSK269962A |
Esophageal cancer |
0.00980443 |
Resistant |
| ENSG00000260367.1 |
GSK269962A |
Esophageal cancer |
0.039583015 |
Resistant |
| ENSG00000260418.1 |
GSK269962A |
Esophageal cancer |
0.005866555 |
Resistant |
| ENSG00000260735.1 |
GSK269962A |
Esophageal cancer |
0.020116828 |
Resistant |
| ENSG00000260751.2 |
GSK269962A |
Esophageal cancer |
0.036729762 |
Resistant |
| ENSG00000260774.1 |
GSK269962A |
Esophageal cancer |
0.023234329 |
Resistant |
| ENSG00000260814.2 |
GSK269962A |
Esophageal cancer |
0.001773032 |
Resistant |
| ENSG00000260927.1 |
GSK269962A |
Esophageal cancer |
0.032048753 |
Resistant |
| ENSG00000261005.1 |
GSK269962A |
Esophageal cancer |
0.035556031 |
Resistant |
| ENSG00000261098.1 |
GSK269962A |
Esophageal cancer |
0.042976117 |
Resistant |
| ENSG00000261373.1 |
GSK269962A |
Esophageal cancer |
0.022135577 |
Resistant |
| ENSG00000261428.1 |
GSK269962A |
Esophageal cancer |
0.046251545 |
Resistant |
| ENSG00000261474.1 |
GSK269962A |
Esophageal cancer |
0.045842247 |
Resistant |
| ENSG00000261533.1 |
GSK269962A |
Esophageal cancer |
0.043193297 |
Resistant |
| ENSG00000261582.1 |
GSK269962A |
Esophageal cancer |
0.018826502 |
Resistant |
| ENSG00000261737.1 |
GSK269962A |
Esophageal cancer |
0.039246221 |
Resistant |
| ENSG00000262147.1 |
GSK269962A |
Esophageal cancer |
0.002844085 |
Resistant |
| ENSG00000262678.1 |
GSK269962A |
Esophageal cancer |
0.046203435 |
Resistant |
| ENSG00000263182.1 |
GSK269962A |
Esophageal cancer |
0.012534489 |
Resistant |
| ENSG00000263244.1 |
GSK269962A |
Esophageal cancer |
0.029429231 |
Resistant |
| ENSG00000263350.1 |
GSK269962A |
Esophageal cancer |
0.043642501 |
Resistant |
| ENSG00000264247.1 |
GSK269962A |
Esophageal cancer |
0.037897378 |
Resistant |
| ENSG00000265800.1 |
GSK269962A |
Esophageal cancer |
0.020908262 |
Resistant |
| ENSG00000266970.1 |
GSK269962A |
Esophageal cancer |
0.025185378 |
Resistant |
| ENSG00000267221.1 |
GSK269962A |
Esophageal cancer |
0.039207415 |
Resistant |
| ENSG00000267682.1 |
GSK269962A |
Esophageal cancer |
0.041306393 |
Resistant |
| ENSG00000267765.1 |
GSK269962A |
Esophageal cancer |
0.000365169 |
Resistant |
| ENSG00000267858.1 |
GSK269962A |
Esophageal cancer |
0.026381432 |
Resistant |
| ENSG00000267939.1 |
GSK269962A |
Esophageal cancer |
0.000949784 |
Resistant |
| ENSG00000269044.1 |
GSK269962A |
Esophageal cancer |
0.030461221 |
Resistant |
| ENSG00000269386.1 |
GSK269962A |
Esophageal cancer |
0.038424928 |
Resistant |
| ENSG00000269473.1 |
GSK269962A |
Esophageal cancer |
0.038456427 |
Resistant |
| ENSG00000269910.1 |
GSK269962A |
Esophageal cancer |
0.032835414 |
Resistant |
| ENSG00000269940.1 |
GSK269962A |
Esophageal cancer |
0.025430899 |
Resistant |
| ENSG00000269958.1 |
GSK269962A |
Esophageal cancer |
0.009495623 |
Resistant |
| ENSG00000269974.1 |
GSK269962A |
Esophageal cancer |
0.043674864 |
Resistant |
| ENSG00000269996.1 |
GSK269962A |
Esophageal cancer |
0.032495339 |
Resistant |
| ENSG00000269999.1 |
GSK269962A |
Esophageal cancer |
0.034309557 |
Resistant |
| ENSG00000270055.1 |
GSK269962A |
Esophageal cancer |
0.045827999 |
Resistant |
| ENSG00000270095.1 |
GSK269962A |
Esophageal cancer |
0.034749383 |
Resistant |
| ENSG00000271751.1 |
GSK269962A |
Esophageal cancer |
0.029821571 |
Resistant |
| ENSG00000271913.1 |
GSK269962A |
Esophageal cancer |
0.004157232 |
Resistant |
| ENSG00000272003.1 |
GSK269962A |
Esophageal cancer |
0.027382799 |
Resistant |
| ENSG00000272077.1 |
GSK269962A |
Esophageal cancer |
0.046463303 |
Resistant |
| ENSG00000272087.1 |
GSK269962A |
Esophageal cancer |
0.015881714 |
Resistant |
| ENSG00000272141.1 |
GSK269962A |
Esophageal cancer |
0.049130344 |
Resistant |
| ENSG00000272172.1 |
GSK269962A |
Esophageal cancer |
0.017769949 |
Resistant |
| ENSG00000272240.1 |
GSK269962A |
Esophageal cancer |
0.031963752 |
Resistant |
| ENSG00000272341.1 |
GSK269962A |
Esophageal cancer |
0.018793936 |
Resistant |
| ENSG00000272645.1 |
GSK269962A |
Esophageal cancer |
0.046166713 |
Resistant |
| ENSG00000272782.1 |
GSK269962A |
Esophageal cancer |
0.027317397 |
Resistant |
| ENSG00000272829.1 |
GSK269962A |
Esophageal cancer |
0.030244638 |
Resistant |
| ENSG00000272888.1 |
GSK269962A |
Esophageal cancer |
0.031221305 |
Resistant |
| ENSG00000273001.1 |
GSK269962A |
Esophageal cancer |
0.009465144 |
Resistant |
| ENSG00000273011.1 |
GSK269962A |
Esophageal cancer |
0.029958928 |
Resistant |
| ENSG00000273117.1 |
GSK269962A |
Esophageal cancer |
0.043249222 |
Resistant |
| ENSG00000273131.1 |
GSK269962A |
Esophageal cancer |
0.015794691 |
Resistant |
| ENSG00000273271.1 |
GSK269962A |
Esophageal cancer |
0.047444494 |
Resistant |
| ENSG00000273290.1 |
GSK269962A |
Esophageal cancer |
0.020962787 |
Resistant |
| ENSG00000273344.1 |
GSK269962A |
Esophageal cancer |
0.026914554 |
Resistant |
| ENSG00000273447.1 |
GSK269962A |
Esophageal cancer |
0.001871421 |
Resistant |
| ENSG00000223462.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.037105359 |
Resistant |
| ENSG00000224812.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.020764361 |
Resistant |
| ENSG00000226328.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.010057388 |
Resistant |
| ENSG00000230826.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.0100112 |
Resistant |
| ENSG00000231770.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.044752646 |
Resistant |
| ENSG00000232342.3 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.023026133 |
Resistant |
| ENSG00000234705.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.027301038 |
Resistant |
| ENSG00000235358.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.018174214 |
Resistant |
| ENSG00000240207.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.006480544 |
Resistant |
| ENSG00000240476.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.037213515 |
Resistant |
| ENSG00000248323.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.033765 |
Resistant |
| ENSG00000251555.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.012558993 |
Resistant |
| ENSG00000253647.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.032367743 |
Resistant |
| ENSG00000253712.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.044767884 |
Resistant |
| ENSG00000254419.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.03431304 |
Resistant |
| ENSG00000257135.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.030672816 |
Resistant |
| ENSG00000257410.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.032378108 |
Resistant |
| ENSG00000265008.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.049401859 |
Resistant |
| ENSG00000268530.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.041921606 |
Resistant |
| ENSG00000269423.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.042635762 |
Resistant |
| ENSG00000271401.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.039385918 |
Resistant |
| ENSG00000272459.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.03834996 |
Resistant |
| ENSG00000272663.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.035671724 |
Resistant |
| ENSG00000142396.6 |
GSK269962A |
Brain lower grade glioma |
0.00861148 |
Resistant |
| ENSG00000178977.3 |
GSK269962A |
Brain lower grade glioma |
0.027194533 |
Resistant |
| ENSG00000179743.2 |
GSK269962A |
Brain lower grade glioma |
0.029405647 |
Resistant |
| ENSG00000181798.2 |
GSK269962A |
Brain lower grade glioma |
0.037901704 |
Resistant |
| ENSG00000189223.9 |
GSK269962A |
Brain lower grade glioma |
0.042560692 |
Resistant |
| ENSG00000204588.5 |
GSK269962A |
Brain lower grade glioma |
0.029657898 |
Resistant |
| ENSG00000204929.7 |
GSK269962A |
Brain lower grade glioma |
0.020803911 |
Resistant |
| ENSG00000204934.6 |
GSK269962A |
Brain lower grade glioma |
0.024932088 |
Resistant |
| ENSG00000205559.3 |
GSK269962A |
Brain lower grade glioma |
0.001929447 |
Resistant |
| ENSG00000206195.6 |
GSK269962A |
Brain lower grade glioma |
0.017090152 |
Resistant |
| ENSG00000214725.3 |
GSK269962A |
Brain lower grade glioma |
0.020017952 |
Resistant |
| ENSG00000215039.2 |
GSK269962A |
Brain lower grade glioma |
0.024790373 |
Resistant |
| ENSG00000215769.4 |
GSK269962A |
Brain lower grade glioma |
0.013952198 |
Resistant |
| ENSG00000224281.4 |
GSK269962A |
Brain lower grade glioma |
0.009005026 |
Resistant |
| ENSG00000224699.4 |
GSK269962A |
Brain lower grade glioma |
0.046118131 |
Resistant |
| ENSG00000224799.1 |
GSK269962A |
Brain lower grade glioma |
0.043194221 |
Resistant |
| ENSG00000225210.5 |
GSK269962A |
Brain lower grade glioma |
0.039168702 |
Resistant |
| ENSG00000225335.2 |
GSK269962A |
Brain lower grade glioma |
0.03010282 |
Resistant |
| ENSG00000225806.3 |
GSK269962A |
Brain lower grade glioma |
0.048657944 |
Resistant |
| ENSG00000226200.2 |
GSK269962A |
Brain lower grade glioma |
0.006068224 |
Resistant |
| ENSG00000226419.2 |
GSK269962A |
Brain lower grade glioma |
0.032875634 |
Resistant |
| ENSG00000226604.2 |
GSK269962A |
Brain lower grade glioma |
0.009027894 |
Resistant |
| ENSG00000226711.2 |
GSK269962A |
Brain lower grade glioma |
0.039649792 |
Resistant |
| ENSG00000227285.1 |
GSK269962A |
Brain lower grade glioma |
0.045916943 |
Resistant |
| ENSG00000227518.2 |
GSK269962A |
Brain lower grade glioma |
0.022753258 |
Resistant |
| ENSG00000227603.1 |
GSK269962A |
Brain lower grade glioma |
0.03111824 |
Resistant |
| ENSG00000227848.1 |
GSK269962A |
Brain lower grade glioma |
0.039000723 |
Resistant |
| ENSG00000227857.2 |
GSK269962A |
Brain lower grade glioma |
0.020371893 |
Resistant |
| ENSG00000228350.1 |
GSK269962A |
Brain lower grade glioma |
0.003061093 |
Resistant |
| ENSG00000228386.2 |
GSK269962A |
Brain lower grade glioma |
0.01726479 |
Resistant |
| ENSG00000229127.1 |
GSK269962A |
Brain lower grade glioma |
0.01178962 |
Resistant |
| ENSG00000229582.2 |
GSK269962A |
Brain lower grade glioma |
0.018314589 |
Resistant |
| ENSG00000230454.1 |
GSK269962A |
Brain lower grade glioma |
0.029322037 |
Resistant |
| ENSG00000230613.1 |
GSK269962A |
Brain lower grade glioma |
0.043541362 |
Resistant |
| ENSG00000230658.1 |
GSK269962A |
Brain lower grade glioma |
0.006086916 |
Resistant |
| ENSG00000231305.3 |
GSK269962A |
Brain lower grade glioma |
0.007442005 |
Resistant |
| ENSG00000231327.1 |
GSK269962A |
Brain lower grade glioma |
0.027773974 |
Resistant |
| ENSG00000231728.2 |
GSK269962A |
Brain lower grade glioma |
0.019241989 |
Resistant |
| ENSG00000232633.3 |
GSK269962A |
Brain lower grade glioma |
0.017165404 |
Resistant |
| ENSG00000232860.3 |
GSK269962A |
Brain lower grade glioma |
0.016636286 |
Resistant |
| ENSG00000233178.3 |
GSK269962A |
Brain lower grade glioma |
0.027207182 |
Resistant |
| ENSG00000233396.3 |
GSK269962A |
Brain lower grade glioma |
0.032709437 |
Resistant |
| ENSG00000233825.1 |
GSK269962A |
Brain lower grade glioma |
0.044239048 |
Resistant |
| ENSG00000233871.1 |
GSK269962A |
Brain lower grade glioma |
0.046475703 |
Resistant |
| ENSG00000234006.1 |
GSK269962A |
Brain lower grade glioma |
0.039898861 |
Resistant |
| ENSG00000234183.1 |
GSK269962A |
Brain lower grade glioma |
0.020919609 |
Resistant |
| ENSG00000234225.2 |
GSK269962A |
Brain lower grade glioma |
0.029380779 |
Resistant |
| ENSG00000234390.4 |
GSK269962A |
Brain lower grade glioma |
0.030183042 |
Resistant |
| ENSG00000234978.1 |
GSK269962A |
Brain lower grade glioma |
0.047800938 |
Resistant |
| ENSG00000235843.1 |
GSK269962A |
Brain lower grade glioma |
0.043268731 |
Resistant |
| ENSG00000236021.1 |
GSK269962A |
Brain lower grade glioma |
0.026357382 |
Resistant |
| ENSG00000236144.2 |
GSK269962A |
Brain lower grade glioma |
0.020557417 |
Resistant |
| ENSG00000236308.1 |
GSK269962A |
Brain lower grade glioma |
0.011965625 |
Resistant |
| ENSG00000236519.1 |
GSK269962A |
Brain lower grade glioma |
0.022187124 |
Resistant |
| ENSG00000239653.1 |
GSK269962A |
Brain lower grade glioma |
0.007760898 |
Resistant |
| ENSG00000240996.1 |
GSK269962A |
Brain lower grade glioma |
0.047413991 |
Resistant |
| ENSG00000241219.1 |
GSK269962A |
Brain lower grade glioma |
0.025839506 |
Resistant |
| ENSG00000244055.1 |
GSK269962A |
Brain lower grade glioma |
0.045079155 |
Resistant |
| ENSG00000244757.1 |
GSK269962A |
Brain lower grade glioma |
0.015251712 |
Resistant |
| ENSG00000245146.2 |
GSK269962A |
Brain lower grade glioma |
0.015707594 |
Resistant |
| ENSG00000245498.2 |
GSK269962A |
Brain lower grade glioma |
0.045451667 |
Resistant |
| ENSG00000245534.2 |
GSK269962A |
Brain lower grade glioma |
0.01594742 |
Resistant |
| ENSG00000245685.2 |
GSK269962A |
Brain lower grade glioma |
0.040662752 |
Resistant |
| ENSG00000245849.2 |
GSK269962A |
Brain lower grade glioma |
0.033104221 |
Resistant |
| ENSG00000246308.1 |
GSK269962A |
Brain lower grade glioma |
0.02925362 |
Resistant |
| ENSG00000247324.2 |
GSK269962A |
Brain lower grade glioma |
0.047437562 |
Resistant |
| ENSG00000247624.2 |
GSK269962A |
Brain lower grade glioma |
0.007015393 |
Resistant |
| ENSG00000248019.2 |
GSK269962A |
Brain lower grade glioma |
0.048955922 |
Resistant |
| ENSG00000248559.1 |
GSK269962A |
Brain lower grade glioma |
0.014674301 |
Resistant |
| ENSG00000248576.1 |
GSK269962A |
Brain lower grade glioma |
0.047699692 |
Resistant |
| ENSG00000248693.1 |
GSK269962A |
Brain lower grade glioma |
0.041722547 |
Resistant |
| ENSG00000249572.1 |
GSK269962A |
Brain lower grade glioma |
0.033344538 |
Resistant |
| ENSG00000249635.1 |
GSK269962A |
Brain lower grade glioma |
0.035881828 |
Resistant |
| ENSG00000249650.1 |
GSK269962A |
Brain lower grade glioma |
0.038119721 |
Resistant |
| ENSG00000249685.1 |
GSK269962A |
Brain lower grade glioma |
0.008874065 |
Resistant |
| ENSG00000250012.1 |
GSK269962A |
Brain lower grade glioma |
0.002758375 |
Resistant |
| ENSG00000250765.1 |
GSK269962A |
Brain lower grade glioma |
0.040658803 |
Resistant |
| ENSG00000251161.2 |
GSK269962A |
Brain lower grade glioma |
0.0270329 |
Resistant |
| ENSG00000253395.1 |
GSK269962A |
Brain lower grade glioma |
0.044503224 |
Resistant |
| ENSG00000253986.1 |
GSK269962A |
Brain lower grade glioma |
0.02602822 |
Resistant |
| ENSG00000254539.1 |
GSK269962A |
Brain lower grade glioma |
0.038188624 |
Resistant |
| ENSG00000255455.2 |
GSK269962A |
Brain lower grade glioma |
0.034045043 |
Resistant |
| ENSG00000255966.1 |
GSK269962A |
Brain lower grade glioma |
0.014078627 |
Resistant |
| ENSG00000256116.1 |
GSK269962A |
Brain lower grade glioma |
0.023932174 |
Resistant |
| ENSG00000256538.1 |
GSK269962A |
Brain lower grade glioma |
0.010310404 |
Resistant |
| ENSG00000257176.1 |
GSK269962A |
Brain lower grade glioma |
0.004342574 |
Resistant |
| ENSG00000258999.1 |
GSK269962A |
Brain lower grade glioma |
0.02006889 |
Resistant |
| ENSG00000259071.1 |
GSK269962A |
Brain lower grade glioma |
0.048333578 |
Resistant |
| ENSG00000259349.1 |
GSK269962A |
Brain lower grade glioma |
0.045581625 |
Resistant |
| ENSG00000259364.1 |
GSK269962A |
Brain lower grade glioma |
0.012700013 |
Resistant |
| ENSG00000259438.1 |
GSK269962A |
Brain lower grade glioma |
0.030563251 |
Resistant |
| ENSG00000259488.1 |
GSK269962A |
Brain lower grade glioma |
0.019859556 |
Resistant |
| ENSG00000259553.2 |
GSK269962A |
Brain lower grade glioma |
0.048926554 |
Resistant |
| ENSG00000259744.1 |
GSK269962A |
Brain lower grade glioma |
0.03868033 |
Resistant |
| ENSG00000260093.1 |
GSK269962A |
Brain lower grade glioma |
0.02148036 |
Resistant |
| ENSG00000260236.1 |
GSK269962A |
Brain lower grade glioma |
0.011063932 |
Resistant |
| ENSG00000260273.1 |
GSK269962A |
Brain lower grade glioma |
0.019070036 |
Resistant |
| ENSG00000260398.1 |
GSK269962A |
Brain lower grade glioma |
0.046396325 |
Resistant |
| ENSG00000260583.1 |
GSK269962A |
Brain lower grade glioma |
0.021467231 |
Resistant |
| ENSG00000260778.2 |
GSK269962A |
Brain lower grade glioma |
0.031352517 |
Resistant |
| ENSG00000260793.2 |
GSK269962A |
Brain lower grade glioma |
0.021754429 |
Resistant |
| ENSG00000260978.1 |
GSK269962A |
Brain lower grade glioma |
0.035585963 |
Resistant |
| ENSG00000260992.1 |
GSK269962A |
Brain lower grade glioma |
0.006247717 |
Resistant |
| ENSG00000261693.1 |
GSK269962A |
Brain lower grade glioma |
0.012406901 |
Resistant |
| ENSG00000261770.1 |
GSK269962A |
Brain lower grade glioma |
0.032622084 |
Resistant |
| ENSG00000262202.3 |
GSK269962A |
Brain lower grade glioma |
0.012577997 |
Resistant |
| ENSG00000263033.1 |
GSK269962A |
Brain lower grade glioma |
0.017164358 |
Resistant |
| ENSG00000264112.1 |
GSK269962A |
Brain lower grade glioma |
0.013091261 |
Resistant |
| ENSG00000265185.2 |
GSK269962A |
Brain lower grade glioma |
0.047771708 |
Resistant |
| ENSG00000265399.1 |
GSK269962A |
Brain lower grade glioma |
0.044306948 |
Resistant |
| ENSG00000265992.1 |
GSK269962A |
Brain lower grade glioma |
0.043212539 |
Resistant |
| ENSG00000267201.1 |
GSK269962A |
Brain lower grade glioma |
0.035549029 |
Resistant |
| ENSG00000267248.1 |
GSK269962A |
Brain lower grade glioma |
0.039054851 |
Resistant |
| ENSG00000267342.1 |
GSK269962A |
Brain lower grade glioma |
0.04052479 |
Resistant |
| ENSG00000269892.1 |
GSK269962A |
Brain lower grade glioma |
0.039656096 |
Resistant |
| ENSG00000269921.1 |
GSK269962A |
Brain lower grade glioma |
0.002675027 |
Resistant |
| ENSG00000270001.1 |
GSK269962A |
Brain lower grade glioma |
0.012253941 |
Resistant |
| ENSG00000270022.2 |
GSK269962A |
Brain lower grade glioma |
0.043048024 |
Resistant |
| ENSG00000270067.1 |
GSK269962A |
Brain lower grade glioma |
0.031535873 |
Resistant |
| ENSG00000270091.1 |
GSK269962A |
Brain lower grade glioma |
0.025726624 |
Resistant |
| ENSG00000270103.2 |
GSK269962A |
Brain lower grade glioma |
0.015528209 |
Resistant |
| ENSG00000270482.1 |
GSK269962A |
Brain lower grade glioma |
0.033169064 |
Resistant |
| ENSG00000271427.1 |
GSK269962A |
Brain lower grade glioma |
0.041687675 |
Resistant |
| ENSG00000271849.1 |
GSK269962A |
Brain lower grade glioma |
0.04195438 |
Resistant |
| ENSG00000271914.1 |
GSK269962A |
Brain lower grade glioma |
0.007103758 |
Resistant |
| ENSG00000272087.1 |
GSK269962A |
Brain lower grade glioma |
0.009312174 |
Resistant |
| ENSG00000272275.1 |
GSK269962A |
Brain lower grade glioma |
0.027260793 |
Resistant |
| ENSG00000272349.1 |
GSK269962A |
Brain lower grade glioma |
0.030802022 |
Resistant |
| ENSG00000272368.1 |
GSK269962A |
Brain lower grade glioma |
0.002352249 |
Resistant |
| ENSG00000272688.1 |
GSK269962A |
Brain lower grade glioma |
0.02692163 |
Resistant |
| ENSG00000272828.1 |
GSK269962A |
Brain lower grade glioma |
0.008053079 |
Resistant |
| ENSG00000272892.1 |
GSK269962A |
Brain lower grade glioma |
0.040853027 |
Resistant |
| ENSG00000272902.1 |
GSK269962A |
Brain lower grade glioma |
0.038654273 |
Resistant |
| ENSG00000272954.1 |
GSK269962A |
Brain lower grade glioma |
0.036672533 |
Resistant |
| ENSG00000273001.1 |
GSK269962A |
Brain lower grade glioma |
0.045316426 |
Resistant |
| ENSG00000273075.1 |
GSK269962A |
Brain lower grade glioma |
0.047184878 |
Resistant |
| ENSG00000273190.1 |
GSK269962A |
Brain lower grade glioma |
0.020577254 |
Resistant |
| ENSG00000273243.1 |
GSK269962A |
Brain lower grade glioma |
0.033856234 |
Resistant |
| ENSG00000273253.1 |
GSK269962A |
Brain lower grade glioma |
0.007822578 |
Resistant |
| ENSG00000273289.1 |
GSK269962A |
Brain lower grade glioma |
0.030186728 |
Resistant |
| ENSG00000273290.1 |
GSK269962A |
Brain lower grade glioma |
0.015972238 |
Resistant |
| ENSG00000273297.1 |
GSK269962A |
Brain lower grade glioma |
0.046200138 |
Resistant |
| ENSG00000273344.1 |
GSK269962A |
Brain lower grade glioma |
0.045763655 |
Resistant |
| ENSG00000273424.1 |
GSK269962A |
Brain lower grade glioma |
0.025097573 |
Resistant |
| ENSG00000273483.1 |
GSK269962A |
Brain lower grade glioma |
0.020427946 |
Resistant |
| ENSG00000174171.4 |
GSK269962A |
Lung squamous cell carcinoma |
0.020442787 |
Resistant |
| ENSG00000185433.4 |
GSK269962A |
Lung squamous cell carcinoma |
0.046041148 |
Resistant |
| ENSG00000186056.5 |
GSK269962A |
Lung squamous cell carcinoma |
0.032709318 |
Resistant |
| ENSG00000214851.4 |
GSK269962A |
Lung squamous cell carcinoma |
0.041663843 |
Resistant |
| ENSG00000215863.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.028742421 |
Resistant |
| ENSG00000223442.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.026384066 |
Resistant |
| ENSG00000223685.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.018313921 |
Resistant |
| ENSG00000223692.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.048068698 |
Resistant |
| ENSG00000223759.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.001734491 |
Resistant |
| ENSG00000224460.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.022687323 |
Resistant |
| ENSG00000224481.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.04475616 |
Resistant |
| ENSG00000226067.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.00617104 |
Resistant |
| ENSG00000226562.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.046877246 |
Resistant |
| ENSG00000228079.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.022215375 |
Resistant |
| ENSG00000228124.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.033762788 |
Resistant |
| ENSG00000228192.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.038029849 |
Resistant |
| ENSG00000228886.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.031403096 |
Resistant |
| ENSG00000228989.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.035520697 |
Resistant |
| ENSG00000229111.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.010608902 |
Resistant |
| ENSG00000230423.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.010537638 |
Resistant |
| ENSG00000230747.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.025452976 |
Resistant |
| ENSG00000231185.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.041825079 |
Resistant |
| ENSG00000231551.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.042798693 |
Resistant |
| ENSG00000231721.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.033721922 |
Resistant |
| ENSG00000232151.5 |
GSK269962A |
Lung squamous cell carcinoma |
0.047005083 |
Resistant |
| ENSG00000232458.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.003639935 |
Resistant |
| ENSG00000232600.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.033202088 |
Resistant |
| ENSG00000232618.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.020632001 |
Resistant |
| ENSG00000233220.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.023448661 |
Resistant |
| ENSG00000233421.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.033696 |
Resistant |
| ENSG00000233785.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.037944438 |
Resistant |
| ENSG00000233825.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.010968811 |
Resistant |
| ENSG00000234197.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.005497403 |
Resistant |
| ENSG00000234245.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.021174008 |
Resistant |
| ENSG00000234263.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.032874485 |
Resistant |
| ENSG00000234292.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.029670504 |
Resistant |
| ENSG00000234393.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.026641254 |
Resistant |
| ENSG00000235214.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.037276945 |
Resistant |
| ENSG00000235398.4 |
GSK269962A |
Lung squamous cell carcinoma |
0.003130488 |
Resistant |
| ENSG00000235999.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.00233377 |
Resistant |
| ENSG00000236318.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.021964597 |
Resistant |
| ENSG00000236472.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.00486373 |
Resistant |
| ENSG00000236943.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.000399936 |
Resistant |
| ENSG00000237772.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.041925309 |
Resistant |
| ENSG00000237943.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.010707559 |
Resistant |
| ENSG00000240549.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.013658294 |
Resistant |
| ENSG00000240875.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.023928575 |
Resistant |
| ENSG00000241313.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.032382489 |
Resistant |
| ENSG00000244041.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.026363078 |
Resistant |
| ENSG00000245105.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.032402434 |
Resistant |
| ENSG00000246145.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.039913853 |
Resistant |
| ENSG00000246422.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.004557794 |
Resistant |
| ENSG00000246582.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.043434108 |
Resistant |
| ENSG00000248100.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.025818231 |
Resistant |
| ENSG00000248866.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.034613943 |
Resistant |
| ENSG00000249673.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.021072893 |
Resistant |
| ENSG00000250129.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.024555369 |
Resistant |
| ENSG00000250714.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.037527342 |
Resistant |
| ENSG00000250900.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.000374105 |
Resistant |
| ENSG00000253167.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.046993304 |
Resistant |
| ENSG00000253911.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.040726139 |
Resistant |
| ENSG00000253930.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.021585178 |
Resistant |
| ENSG00000254094.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.049876238 |
Resistant |
| ENSG00000254315.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.003299967 |
Resistant |
| ENSG00000254353.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.036463369 |
Resistant |
| ENSG00000254389.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.034421385 |
Resistant |
| ENSG00000254694.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.001289943 |
Resistant |
| ENSG00000254814.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.042704753 |
Resistant |
| ENSG00000254985.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.040809345 |
Resistant |
| ENSG00000255237.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.037956449 |
Resistant |
| ENSG00000255320.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.000990099 |
Resistant |
| ENSG00000255651.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.038781297 |
Resistant |
| ENSG00000255992.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.02323969 |
Resistant |
| ENSG00000257964.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.041551721 |
Resistant |
| ENSG00000258274.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.046833403 |
Resistant |
| ENSG00000259628.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.023415377 |
Resistant |
| ENSG00000259687.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.015791288 |
Resistant |
| ENSG00000259883.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.046291272 |
Resistant |
| ENSG00000260059.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.009285196 |
Resistant |
| ENSG00000260441.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.029371349 |
Resistant |
| ENSG00000260493.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.0311315 |
Resistant |
| ENSG00000260841.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.048859926 |
Resistant |
| ENSG00000260871.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.023159185 |
Resistant |
| ENSG00000260955.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.021875156 |
Resistant |
| ENSG00000261780.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.023247614 |
Resistant |
| ENSG00000262001.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.037168018 |
Resistant |
| ENSG00000264339.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.024633874 |
Resistant |
| ENSG00000264548.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.002930094 |
Resistant |
| ENSG00000265490.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.038307627 |
Resistant |
| ENSG00000265692.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.004778088 |
Resistant |
| ENSG00000266176.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.025126324 |
Resistant |
| ENSG00000266654.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.046042918 |
Resistant |
| ENSG00000266900.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.026567792 |
Resistant |
| ENSG00000268333.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.04636042 |
Resistant |
| ENSG00000269901.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.017218063 |
Resistant |
| ENSG00000269924.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.031408183 |
Resistant |
| ENSG00000270159.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.029883094 |
Resistant |
| ENSG00000271344.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.04729309 |
Resistant |
| ENSG00000272030.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.024221688 |
Resistant |
| ENSG00000272172.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.034628262 |
Resistant |
| ENSG00000272226.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.000209047 |
Resistant |
| ENSG00000272457.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.036718581 |
Resistant |
| ENSG00000272755.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.047888468 |
Resistant |
| ENSG00000273002.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.014566983 |
Resistant |
| ENSG00000225733.1 |
GSK269962A |
Breast invasive carcinoma |
0.023657703 |
Sensitive |
| ENSG00000227192.1 |
GSK269962A |
Breast invasive carcinoma |
0.016953875 |
Sensitive |
| ENSG00000227888.3 |
GSK269962A |
Breast invasive carcinoma |
0.039755795 |
Sensitive |
| ENSG00000228350.1 |
GSK269962A |
Breast invasive carcinoma |
0.013928693 |
Sensitive |
| ENSG00000228775.3 |
GSK269962A |
Breast invasive carcinoma |
0.026626297 |
Sensitive |
| ENSG00000228878.3 |
GSK269962A |
Breast invasive carcinoma |
0.001267605 |
Sensitive |
| ENSG00000229728.1 |
GSK269962A |
Breast invasive carcinoma |
0.005285393 |
Sensitive |
| ENSG00000230850.3 |
GSK269962A |
Breast invasive carcinoma |
0.028962611 |
Sensitive |
| ENSG00000231519.1 |
GSK269962A |
Breast invasive carcinoma |
0.00531891 |
Sensitive |
| ENSG00000232336.1 |
GSK269962A |
Breast invasive carcinoma |
0.036912921 |
Sensitive |
| ENSG00000233008.1 |
GSK269962A |
Breast invasive carcinoma |
0.044987345 |
Sensitive |
| ENSG00000233452.2 |
GSK269962A |
Breast invasive carcinoma |
0.015574452 |
Sensitive |
| ENSG00000236432.3 |
GSK269962A |
Breast invasive carcinoma |
0.049306181 |
Sensitive |
| ENSG00000237181.1 |
GSK269962A |
Breast invasive carcinoma |
0.025106137 |
Sensitive |
| ENSG00000237883.1 |
GSK269962A |
Breast invasive carcinoma |
0.036925481 |
Sensitive |
| ENSG00000239335.4 |
GSK269962A |
Breast invasive carcinoma |
0.007227301 |
Sensitive |
| ENSG00000246308.1 |
GSK269962A |
Breast invasive carcinoma |
0.048490297 |
Sensitive |
| ENSG00000246523.3 |
GSK269962A |
Breast invasive carcinoma |
0.029046895 |
Sensitive |
| ENSG00000248275.1 |
GSK269962A |
Breast invasive carcinoma |
0.037341556 |
Sensitive |
| ENSG00000248866.1 |
GSK269962A |
Breast invasive carcinoma |
0.001992998 |
Sensitive |
| ENSG00000250903.4 |
GSK269962A |
Breast invasive carcinoma |
0.008936092 |
Sensitive |
| ENSG00000254610.1 |
GSK269962A |
Breast invasive carcinoma |
0.003776103 |
Sensitive |
| ENSG00000254977.1 |
GSK269962A |
Breast invasive carcinoma |
0.040370672 |
Sensitive |
| ENSG00000255857.1 |
GSK269962A |
Breast invasive carcinoma |
0.041653097 |
Sensitive |
| ENSG00000258285.1 |
GSK269962A |
Breast invasive carcinoma |
0.035678811 |
Sensitive |
| ENSG00000258811.1 |
GSK269962A |
Breast invasive carcinoma |
0.037739598 |
Sensitive |
| ENSG00000259628.1 |
GSK269962A |
Breast invasive carcinoma |
0.042675826 |
Sensitive |
| ENSG00000260095.1 |
GSK269962A |
Breast invasive carcinoma |
0.01467968 |
Sensitive |
| ENSG00000260349.1 |
GSK269962A |
Breast invasive carcinoma |
0.037785323 |
Sensitive |
| ENSG00000260579.1 |
GSK269962A |
Breast invasive carcinoma |
0.04144553 |
Sensitive |
| ENSG00000261015.1 |
GSK269962A |
Breast invasive carcinoma |
0.023120614 |
Sensitive |
| ENSG00000261140.1 |
GSK269962A |
Breast invasive carcinoma |
0.023420228 |
Sensitive |
| ENSG00000261189.1 |
GSK269962A |
Breast invasive carcinoma |
0.029849967 |
Sensitive |
| ENSG00000261924.1 |
GSK269962A |
Breast invasive carcinoma |
0.00157248 |
Sensitive |
| ENSG00000262165.1 |
GSK269962A |
Breast invasive carcinoma |
0.04646482 |
Sensitive |
| ENSG00000262944.1 |
GSK269962A |
Breast invasive carcinoma |
0.039143038 |
Sensitive |
| ENSG00000263072.1 |
GSK269962A |
Breast invasive carcinoma |
0.025358311 |
Sensitive |
| ENSG00000263843.1 |
GSK269962A |
Breast invasive carcinoma |
0.021430829 |
Sensitive |
| ENSG00000266469.1 |
GSK269962A |
Breast invasive carcinoma |
0.048324385 |
Sensitive |
| ENSG00000267080.1 |
GSK269962A |
Breast invasive carcinoma |
0.01957457 |
Sensitive |
| ENSG00000267198.1 |
GSK269962A |
Breast invasive carcinoma |
0.038441429 |
Sensitive |
| ENSG00000267246.1 |
GSK269962A |
Breast invasive carcinoma |
0.034245596 |
Sensitive |
| ENSG00000267278.1 |
GSK269962A |
Breast invasive carcinoma |
0.037869578 |
Sensitive |
| ENSG00000267296.2 |
GSK269962A |
Breast invasive carcinoma |
0.043130866 |
Sensitive |
| ENSG00000268015.1 |
GSK269962A |
Breast invasive carcinoma |
0.018191455 |
Sensitive |
| ENSG00000270109.1 |
GSK269962A |
Breast invasive carcinoma |
0.024685584 |
Sensitive |
| ENSG00000271228.1 |
GSK269962A |
Breast invasive carcinoma |
0.048966172 |
Sensitive |
| ENSG00000272812.1 |
GSK269962A |
Breast invasive carcinoma |
0.009496212 |
Sensitive |
| ENSG00000272902.1 |
GSK269962A |
Breast invasive carcinoma |
0.038544084 |
Sensitive |
| ENSG00000273355.1 |
GSK269962A |
Breast invasive carcinoma |
0.010266014 |
Sensitive |
| ENSG00000273356.1 |
GSK269962A |
Breast invasive carcinoma |
0.021154725 |
Sensitive |
| ENSG00000273432.1 |
GSK269962A |
Breast invasive carcinoma |
0.029106076 |
Sensitive |
| ENSG00000223401.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049154488 |
Sensitive |
| ENSG00000225331.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012240984 |
Sensitive |
| ENSG00000225602.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029258114 |
Sensitive |
| ENSG00000225751.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043679588 |
Sensitive |
| ENSG00000231131.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036106656 |
Sensitive |
| ENSG00000231329.3 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02762618 |
Sensitive |
| ENSG00000232377.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001046764 |
Sensitive |
| ENSG00000232542.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034389087 |
Sensitive |
| ENSG00000233613.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035069147 |
Sensitive |
| ENSG00000234945.3 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033096389 |
Sensitive |
| ENSG00000248734.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040821535 |
Sensitive |
| ENSG00000249207.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032254377 |
Sensitive |
| ENSG00000251018.2 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000499524 |
Sensitive |
| ENSG00000253552.3 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019254566 |
Sensitive |
| ENSG00000255202.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047741874 |
Sensitive |
| ENSG00000258136.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007971018 |
Sensitive |
| ENSG00000258867.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049813914 |
Sensitive |
| ENSG00000258946.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041605935 |
Sensitive |
| ENSG00000260774.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004377349 |
Sensitive |
| ENSG00000262265.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002361624 |
Sensitive |
| ENSG00000268499.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0000186 |
Sensitive |
| ENSG00000269653.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021664436 |
Sensitive |
| ENSG00000269942.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020529374 |
Sensitive |
| ENSG00000270133.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04335966 |
Sensitive |
| ENSG00000273030.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008908676 |
Sensitive |
| ENSG00000273375.1 |
GSK269962A |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035267707 |
Sensitive |
| ENSG00000236449.1 |
GSK269962A |
Esophageal cancer |
0.03347573 |
Sensitive |
| ENSG00000215159.3 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.04708771 |
Sensitive |
| ENSG00000223882.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.00516212 |
Sensitive |
| ENSG00000225057.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.005557098 |
Sensitive |
| ENSG00000226266.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.031945942 |
Sensitive |
| ENSG00000226649.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.039720318 |
Sensitive |
| ENSG00000226758.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.033890136 |
Sensitive |
| ENSG00000227050.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.001462061 |
Sensitive |
| ENSG00000227256.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.000577625 |
Sensitive |
| ENSG00000227409.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.042965728 |
Sensitive |
| ENSG00000227680.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.002823114 |
Sensitive |
| ENSG00000227885.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.029548458 |
Sensitive |
| ENSG00000228386.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.037387463 |
Sensitive |
| ENSG00000228614.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.010083557 |
Sensitive |
| ENSG00000230498.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.049183202 |
Sensitive |
| ENSG00000231512.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.001152169 |
Sensitive |
| ENSG00000232545.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.047386117 |
Sensitive |
| ENSG00000232712.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.016534241 |
Sensitive |
| ENSG00000233367.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.04558765 |
Sensitive |
| ENSG00000233848.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.027879095 |
Sensitive |
| ENSG00000236545.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.048717318 |
Sensitive |
| ENSG00000237737.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.035388317 |
Sensitive |
| ENSG00000243485.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.048248468 |
Sensitive |
| ENSG00000248790.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.032057718 |
Sensitive |
| ENSG00000249084.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.012705504 |
Sensitive |
| ENSG00000249476.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.010203799 |
Sensitive |
| ENSG00000250751.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.0000472 |
Sensitive |
| ENSG00000253476.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.013758628 |
Sensitive |
| ENSG00000253708.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.012686322 |
Sensitive |
| ENSG00000254362.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.049763831 |
Sensitive |
| ENSG00000254691.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.038794928 |
Sensitive |
| ENSG00000254694.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.011201118 |
Sensitive |
| ENSG00000255487.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.029706244 |
Sensitive |
| ENSG00000256789.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.018093044 |
Sensitive |
| ENSG00000257964.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.026483083 |
Sensitive |
| ENSG00000258693.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.027870247 |
Sensitive |
| ENSG00000259418.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.004299526 |
Sensitive |
| ENSG00000259553.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.027253951 |
Sensitive |
| ENSG00000260814.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.024348553 |
Sensitive |
| ENSG00000261096.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.0125733 |
Sensitive |
| ENSG00000261280.2 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.011676172 |
Sensitive |
| ENSG00000261578.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.034337583 |
Sensitive |
| ENSG00000261775.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.022423642 |
Sensitive |
| ENSG00000261872.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.041243051 |
Sensitive |
| ENSG00000262115.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.026555175 |
Sensitive |
| ENSG00000262678.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.027869207 |
Sensitive |
| ENSG00000264078.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.018023681 |
Sensitive |
| ENSG00000264812.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.032480292 |
Sensitive |
| ENSG00000264829.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.042989924 |
Sensitive |
| ENSG00000265791.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.002705881 |
Sensitive |
| ENSG00000266236.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.039007007 |
Sensitive |
| ENSG00000266237.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.034550275 |
Sensitive |
| ENSG00000266411.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.029574496 |
Sensitive |
| ENSG00000266498.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.013750483 |
Sensitive |
| ENSG00000266541.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.043893952 |
Sensitive |
| ENSG00000266941.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.028830861 |
Sensitive |
| ENSG00000267003.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.028448024 |
Sensitive |
| ENSG00000267136.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.046451582 |
Sensitive |
| ENSG00000267366.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.046455948 |
Sensitive |
| ENSG00000267702.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.044267788 |
Sensitive |
| ENSG00000268743.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.024295354 |
Sensitive |
| ENSG00000269091.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.016062842 |
Sensitive |
| ENSG00000269487.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.026084162 |
Sensitive |
| ENSG00000270048.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.010416365 |
Sensitive |
| ENSG00000271948.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.00616279 |
Sensitive |
| ENSG00000272489.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.019357821 |
Sensitive |
| ENSG00000272885.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.004443886 |
Sensitive |
| ENSG00000273066.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.000272344 |
Sensitive |
| ENSG00000273113.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.030875421 |
Sensitive |
| ENSG00000273309.1 |
GSK269962A |
Chronic Lymphocytic Leukemia |
0.031251578 |
Sensitive |
| ENSG00000228028.2 |
GSK269962A |
Brain lower grade glioma |
0.00091565 |
Sensitive |
| ENSG00000231486.3 |
GSK269962A |
Brain lower grade glioma |
0.027283971 |
Sensitive |
| ENSG00000249593.2 |
GSK269962A |
Brain lower grade glioma |
0.003455537 |
Sensitive |
| ENSG00000254129.1 |
GSK269962A |
Brain lower grade glioma |
0.019056162 |
Sensitive |
| ENSG00000259294.1 |
GSK269962A |
Brain lower grade glioma |
0.028043672 |
Sensitive |
| ENSG00000259682.1 |
GSK269962A |
Brain lower grade glioma |
0.031382905 |
Sensitive |
| ENSG00000260578.1 |
GSK269962A |
Brain lower grade glioma |
0.008994125 |
Sensitive |
| ENSG00000260635.1 |
GSK269962A |
Brain lower grade glioma |
0.007503166 |
Sensitive |
| ENSG00000260953.1 |
GSK269962A |
Brain lower grade glioma |
0.045930879 |
Sensitive |
| ENSG00000262999.1 |
GSK269962A |
Brain lower grade glioma |
0.005758987 |
Sensitive |
| ENSG00000266987.1 |
GSK269962A |
Brain lower grade glioma |
0.024648503 |
Sensitive |
| ENSG00000267199.1 |
GSK269962A |
Brain lower grade glioma |
0.049328629 |
Sensitive |
| ENSG00000267449.1 |
GSK269962A |
Brain lower grade glioma |
0.022205638 |
Sensitive |
| ENSG00000269680.1 |
GSK269962A |
Brain lower grade glioma |
0.010904113 |
Sensitive |
| ENSG00000272219.1 |
GSK269962A |
Brain lower grade glioma |
0.000778003 |
Sensitive |
| ENSG00000125804.9 |
GSK269962A |
Lung squamous cell carcinoma |
0.006839868 |
Sensitive |
| ENSG00000164621.5 |
GSK269962A |
Lung squamous cell carcinoma |
0.011209654 |
Sensitive |
| ENSG00000172250.10 |
GSK269962A |
Lung squamous cell carcinoma |
0.020611486 |
Sensitive |
| ENSG00000197332.7 |
GSK269962A |
Lung squamous cell carcinoma |
0.018754294 |
Sensitive |
| ENSG00000197813.4 |
GSK269962A |
Lung squamous cell carcinoma |
0.039070664 |
Sensitive |
| ENSG00000203279.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.039887599 |
Sensitive |
| ENSG00000203801.4 |
GSK269962A |
Lung squamous cell carcinoma |
0.034173509 |
Sensitive |
| ENSG00000213971.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.038490332 |
Sensitive |
| ENSG00000223478.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.049661677 |
Sensitive |
| ENSG00000223704.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.008203242 |
Sensitive |
| ENSG00000224596.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.047718736 |
Sensitive |
| ENSG00000225331.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.039535841 |
Sensitive |
| ENSG00000225555.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.027344128 |
Sensitive |
| ENSG00000225643.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.037451992 |
Sensitive |
| ENSG00000226864.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.04852951 |
Sensitive |
| ENSG00000227544.4 |
GSK269962A |
Lung squamous cell carcinoma |
0.007151731 |
Sensitive |
| ENSG00000227895.4 |
GSK269962A |
Lung squamous cell carcinoma |
0.019573242 |
Sensitive |
| ENSG00000228065.6 |
GSK269962A |
Lung squamous cell carcinoma |
0.008186679 |
Sensitive |
| ENSG00000230323.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.014235563 |
Sensitive |
| ENSG00000230536.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.007931772 |
Sensitive |
| ENSG00000232377.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.042264706 |
Sensitive |
| ENSG00000232542.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.03452206 |
Sensitive |
| ENSG00000232878.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.012709711 |
Sensitive |
| ENSG00000235121.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.043640676 |
Sensitive |
| ENSG00000235989.3 |
GSK269962A |
Lung squamous cell carcinoma |
0.018396943 |
Sensitive |
| ENSG00000236977.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.04237411 |
Sensitive |
| ENSG00000237805.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.002967659 |
Sensitive |
| ENSG00000237883.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.04259535 |
Sensitive |
| ENSG00000238186.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.023886811 |
Sensitive |
| ENSG00000243795.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.045980038 |
Sensitive |
| ENSG00000244063.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.010475378 |
Sensitive |
| ENSG00000246859.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.003510598 |
Sensitive |
| ENSG00000253282.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.012955748 |
Sensitive |
| ENSG00000253369.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.01332572 |
Sensitive |
| ENSG00000255310.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.024210887 |
Sensitive |
| ENSG00000256403.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.020287896 |
Sensitive |
| ENSG00000259088.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.048975105 |
Sensitive |
| ENSG00000261329.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.036891509 |
Sensitive |
| ENSG00000261610.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.046855522 |
Sensitive |
| ENSG00000261654.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.000313099 |
Sensitive |
| ENSG00000262903.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.030732054 |
Sensitive |
| ENSG00000266912.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.048563238 |
Sensitive |
| ENSG00000267143.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.011708371 |
Sensitive |
| ENSG00000267192.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.038555749 |
Sensitive |
| ENSG00000267383.2 |
GSK269962A |
Lung squamous cell carcinoma |
0.048729074 |
Sensitive |
| ENSG00000267429.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.043194485 |
Sensitive |
| ENSG00000267481.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.049103267 |
Sensitive |
| ENSG00000267606.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.041050598 |
Sensitive |
| ENSG00000267886.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.038304328 |
Sensitive |
| ENSG00000268230.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.039339567 |
Sensitive |
| ENSG00000268266.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.011328465 |
Sensitive |
| ENSG00000268316.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.046787936 |
Sensitive |
| ENSG00000268543.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.0226775 |
Sensitive |
| ENSG00000268605.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.029708471 |
Sensitive |
| ENSG00000268895.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.015264092 |
Sensitive |
| ENSG00000269107.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.045993344 |
Sensitive |
| ENSG00000269918.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.025116094 |
Sensitive |
| ENSG00000270039.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.004401715 |
Sensitive |
| ENSG00000270108.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.012411814 |
Sensitive |
| ENSG00000270996.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.047530321 |
Sensitive |
| ENSG00000272375.1 |
GSK269962A |
Lung squamous cell carcinoma |
0.004201074 |
Sensitive |
